Insulin glargine and lixisenatide and NovoSeven RT with MixPro injection
Determining the interaction of Insulin glargine and lixisenatide and NovoSeven RT with MixPro injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: coagulation factor viia
Brand name: NovoSeven RT with MixPro, Novoseven, NovoSeven RT
Synonyms: NovoSeven RT with MixPro (injection), NovoSeven RT
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Novothyrox
- Insulin glargine and lixisenatide-Noxafil
- Insulin glargine and lixisenatide-Noxafil (Posaconazole Delayed-Release Tablets)
- Insulin glargine and lixisenatide-Noxafil (Posaconazole Injection)
- Insulin glargine and lixisenatide-Noxafil (Posaconazole Oral Suspension)
- Insulin glargine and lixisenatide-Noxafil Intravenous
- NovoSeven RT with MixPro injection-Insulin glargine and lixisenatide Subcutaneous
- NovoSeven RT with MixPro injection-Insulin glargine, recombinant Subcutaneous
- NovoSeven RT with MixPro injection-Insulin glulisine
- NovoSeven RT with MixPro injection-Insulin Glulisine (Cartridges and Pens)
- NovoSeven RT with MixPro injection-Insulin Glulisine (Vials)
- NovoSeven RT with MixPro injection-Insulin glulisine Subcutaneous